RecruitingPhase 2NCT02918188

Therapeutic Effects of Hydrogen on Steroid-refractory/or Steroid-dependent cGVHD

Therapeutic Effects of Hydrogen on Steroid-refractory/or Steroid-dependent Chronic Graft-versus-host-disease

Sponsor

Navy General Hospital, Beijing

Enrollment

21 participants

Start Date

Jan 1, 2016

Study Type

INTERVENTIONAL

Conditions

Chronic Graft Versus Host Disease

Summary

This study suggested that hydrogen has a potential as an effective and safe therapeutic agent on cGVHD.

Eligibility

Max Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Hydrogen for people with chronic graft versus host disease. The study is currently recruiting participants at 1 location. People eligible for this study include up to age 65 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.